KartavyaDesk
newsBioconMergers and AcquisitionsBiotechnology

Biocon to merge biologics unit; to acquire stake held by Serum, Mylan

Kartavya Desk Staff

Biocon will acquire the remaining stake in Biocon Biologics Limited through a share swap, valuing Biocon Biologics at $5.5 billion

AI-assisted content, editorially reviewed by Kartavya Desk Staff.

About Kartavya Desk Staff

Articles in our archive published before our editorial team was expanded. Legacy content is periodically reviewed and updated by our current editors.

All News